PEN:NYSE
Penumbra Inc
US$ 318.00
arrow_downward
-0.11%(-0.34) Siku 1
US$ 319.65
arrow_upward
+0.52% (+1.65)bedtimeBaada ya saa
Imefungwa: 1 Okt, 16:00:04 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya PEN...
Fungua
US$ 318.38
Juu
US$ 318.92
Chini
US$ 317.92
Mtaji wa soko
12.53B
Wastani wa kiasi cha mauzo
elfu 350.49
Kiasi cha mauzo ya hisa
20.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
78.10
Juu kwa wiki 52
US$ 362.41
Chini kwa wiki 52
US$ 221.26
EPS
US$ 4.07
Beta
0.70
Hisa za wawekezaji
39.39M
Idadi ya wafanyakazi
elfu 5
Fungua
US$ 318.38
Juu
US$ 318.92
Chini
US$ 317.92
Mtaji wa soko
12.53B
Wastani wa kiasi cha mauzo
elfu 350.49
Kiasi cha mauzo ya hisa
20.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
78.10
Juu kwa wiki 52
US$ 362.41
Chini kwa wiki 52
US$ 221.26
EPS
US$ 4.07
Beta
0.70
Hisa za wawekezaji
39.39M
Idadi ya wafanyakazi
elfu 5
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 16 zilizopita
Penumbra stock breaks below 50-day average
Zacks
·
saa 18 zilizopita
IART vs. PEN: Which Stock Is the Better Value Option?
Wasifu
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
Kuhusu Penumbra Inc
Afisa Mkuu Mtendaji (CEO)Adam Elsesser
Wafanyakazielfu 4.7
Lilianzishwa2004
Makao makuu-
Sekta-
Tovutipenumbrainc.com